2. Zakošek Pipan M, Prpar Mihevc S, Štrbenc M, Košak U, German Ilić I, Trontelj J, Žakelj S, Gobec S, Pavlin D, Majdič G. Treatment of canine cognitive dysfunction with novel butyrylcholinesterase inhibitor. Sci Rep. 2021;11:18098.
3. Koh R. Treating cognitive dysfunction syndrome with acupuncture and herbal medicine. Paper presented at: World Small Animal Veterinary Association Congress Proceedings (WSAVA); 2018 sep 25-28; Singapore. Singapore: WSAVA, 2018.
4. Prpar Mihevc S, Majdič G. Canine cognitive dysfunction and Alzheimer’s disease: two facets of the same disease? Front Neurosci. 2019;13:604.
5. Rose WJ, Sargeant JM, Hanna WJ, Kelton D, Wolfe DM, Wisener LV. A scoping review of the evidence for efficacy of acupuncture in companion animals. Anim Health Res Rev. 2017;18:177-185.
6. Kline KL. Complementary and alternative medicine for neurologic disorders. Clin Tech Small Anim Pract. 2002;17:25-33.
7. Zhou S, Dong L, He Y, Xiao H. Acupuncture plus herbal medicine for Alzheimer’s disease: a systematic review and meta-analysis. Am J Chin Med. 2017;45:1327-1344.
8. Dong L, May BH, Feng M, Hyde AJ, Tan HY, Guo X, Zhang AL, Lu C, Xue CC. Chinese herbal medicine for mild cognitive impairment: a systematic review and meta-analysis of cognitive outcomes. Phytother Res. 2016;30:1592-1604.
9. Jeong HG, Han C. Diagnosis and treatment of dementia in primary care. J Korean Med Assoc. 2013;56:1104-1112.
10. Jung IC. Korean Medicine Clinical Practice Guideline for Dementia, 2021. The Society of Korean Medicine Neuropsychiatry, Yangsan, 2021.
11. Kim HJ, Im H. Assessment of dementia. Brain Neurorehabil. 2015;8:11-18.
12. Tarter RE, Edwards KL. Neuropsychological Batteries. In: Incagnoli T, Goldstein G, Golden CJ, eds. Clinical Application of Neuropsychological Test Batteries. pp. 135-153, Springer, Boston, 1986.
13. González-Martínez A, Rosado B, Pesini P, García-Belenguer S, Palacio J, Villegas A, Suárez ML, Santamarina G, Sarasa M. Effect of age and severity of cognitive dysfunction on two simple tasks in pet dogs. Vet J. 2013;198:176-181.
14. Salvin HE, McGreevy PD, Sachdev PS, Valenzuela MJ. The canine cognitive dysfunction rating scale (CCDR): a data-driven and ecologically relevant assessment tool. Vet J. 2011;188:331-336.
15. Madari A, Farbakova J, Katina S, Smolek T, Novak P, Weissova T, Novak M, Zilka N. Assessment of severity and progression of canine cognitive dysfunction syndrome using the CAnine DEmentia Scale (CADES). Appl Anim Behav Sci. 2015;171:138-145.
16. Galasko D, Schmitt F, Thomas R, Jin S, Bennett D; Alzheimer’s Disease Cooperative Study. Detailed assessment of activities of daily living in moderate to severe Alzheimer’s disease. J Int Neuropsychol Soc. 2005;11:446-453.
17. Wade DT, Collin C. The Barthel ADL Index: a standard measure of physical disability? Int Disabil Stud. 1988;10:64-67.
18. Colle M-A, Hauw JJ, Crespeau F, Uchihara T, Akiyama H, Checler F, Pageat P, Duykaerts C. Vascular and parenchymal Abeta deposition in the aging dog: correlation with behavior. Neurobiol Aging. 2000;21:695-704.
19. Hasegawa D, Yayoshi N, Fujita Y, Fujita M, Orima H. Measurement of interthalamic adhesion thickness as a criteria for brain atrophy in dogs with and without cognitive dysfunction (dementia). Vet Radiol Ultrasound. 2005;46:452-457.
20. Siwak-Tapp CT, Head E, Muggenburg BA, Milgram NW, Cotman CW. Region specific neuron loss in the aged canine hippocampus is reduced by enrichment. Neurobiol Aging. 2008;29:39-50.
21. Han JM, Yang WM. A review on Korean medicine and personalized medicine: syndrome-based personalized medicine on the basis of syndrome differentiation and treatment. J Korean Med. 2014;35:40-48.
22. Jiang WY. Therapeutic wisdom in traditional Chinese medicine: a perspective from modern science. Trends Pharmacol Sci. 2005;26:558-563.
23. Lee GE, Moon KS, Kim NK, Chung SY, Jung IC, Kang HW. Preliminary study to develop the Korean medical pathologic aging scale and Korean medical pattern identification for dementia. J Korean Med. 2017;38:111-123.
24. Heo EJ, Kang HW, Jeon WK. Preliminary research for development of instrument for cold-heat & deficiency-excess pattern identification of dementia. Korean J Orient J Physiol Pathol. 2013;27:553-562.
25. Moon HS, Hong WS. A study on the uplift of recipe. J Korean Med Classics. 2001;14:11-51.
26. Heo EJ, Lee SW, Jeon WK, Lyu YS, Kang HW. The evaluation of instrument for cold-heat & deficiency-excess pattern identification of dementia. J Orient Neuropsychiatry. 2015;26:283-292.
27. Xin XD. The sequence of Traditional Medicine syndrome differentiation and treatment. J Korean Med. 1990;11:202-204.
28. Zhu W. Traditional Chinese Medicine Diagnostics. China Traditional Chinese Medicine Publishing House, Beijing, 2002.
29. Lee M, Lee J, Choi T, Choi J, Jun J. Preferred Reporting Items for Development of Clinical Practice Guideline in Korean Medicine. pp. 7-13, Korea Institute of Oriental Medicine, Daejeon, 2015.
30. Ryu CH, Jung IC, Cho SH, Hwang WW, Kang WC, Lee SR. Preliminary study to develop the instrument of oriental medical evaluation for dementia. J Orient Neuropsychiatry. 2010;21:123-135.
32. Kim YS, Choi KH. Clinical observations on small animal patients treated by Oriental medicine. J Acupunct Res. 2003;20:120-127.
33. Kim DH, Seo BI, Kim BK, Kim GC, Shin SS. Standard principles for the designing of prescriptions: the theory for monarch, minister, adjuvant and dispatcher. Korean J Orient Med Prescr. 2003;11:1-18.
34. Iwasaki K, Kobayashi S, Chimura Y, Taguchi M, Inoue K, Cho S, Akiba T, Arai H, Cyong JC, Sasaki H. A randomized, double-blind, placebo-controlled clinical trial of the Chinese herbal medicine “ba wei di huang wan” in the treatment of dementia. J Am Geriatr Soc. 2004;52:1518-1521.
35. Gu C, Shen T, An H, Yuan C, Zhou J, Ye Q, Liu T, Wang X, Zhang T. Combined therapy of Di-Huang-Yi-Zhi with Donepezil in patients with Parkinson’s disease dementia. Neurosci Lett. 2015;606:13-17.
36. Kim YN, Bae JS, Eom YJ, Lee KS, Yoon HM, Cho SH. Results of Korean medicine treatment in community dwelling elderly with mild cognitive impairment: focusing on the change in cognitive ability. J Orient Neuropsychiatry. 2019;30:185-198.
39. Okahara K, Ishida Y, Hayashi Y, Inoue T, Tsuruta K, Takeuchi K, Yoshimuta H, Kiue K, Ninomiya Y, Kawano J, Yoshida K, Noda S, Tomita S, Fujimoto M, Hosomi J, Mitsuyama Y. Effects of Yokukansan on behavioral and psychological symptoms of dementia in regular treatment for Alzheimer’s disease. Prog Neuropsychopharmacol Biol Psychiatry. 2010;34:532-536.